Segall Bryant & Hamill, LLC Harvard Bioscience Inc Transaction History

Segall Bryant & Hamill, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$3.03 - $5.0 $664,145 - $1.1 Million	-219,190 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$5.0 - $6.65 $3.77 Million - $5.01 Million	-753,171 Reduced 77.46%	219,190 $0
Q2 2018 Aug 08, 2018	SELL	$4.2 - $5.95 $118,591 - $168,004	-28,236 Reduced 2.82%	972,361 $0
Q1 2018 May 16, 2018	BUY	$3.3 - $5.15 $542,120 - $846,036	164,279 Added 19.64%	1,000,597 $0
Q4 2017 Feb 15, 2018	BUY	$3.08 - $3.8 $228,865 - $282,366	74,307 Added 9.75%	836,318 $0
Q3 2017 Nov 14, 2017	BUY	$2.7 - $3.75 $2.06 Million - $2.86 Million	762,011	762,011 $0

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.